Candel Therapeutics Inc. (NASDAQ: CADL)
$5.2800
+1.1450 ( +26.01% ) 988.9K
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Market Data
Open
$5.2800
Previous close
$4.1350
Volume
988.9K
Market cap
$168.71M
Day range
$4.1820 - $5.3490
52 week range
$0.7700 - $14.3000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| def | Proxies and info statements | 3 | May 30, 2024 |
| ars | Annual reports | 1 | May 30, 2024 |
| 8-k | 8K-related | 12 | May 30, 2024 |
| 8-k | 8K-related | 14 | May 23, 2024 |
| 10-q | Quarterly Reports | 76 | May 14, 2024 |
| 8-k | 8K-related | 15 | May 14, 2024 |
| 8-k | 8K-related | 13 | Apr 25, 2024 |
| 10-k/a | Quarterly Reports | 17 | Apr 25, 2024 |
| 8-k | 8K-related | 13 | Apr 11, 2024 |
| 8-k | 8K-related | 13 | Apr 09, 2024 |